ArticleDiabetology international2025

Slow progression of type 1 diabetes associated with pembrolizumab and lenvatinib combination therapy in a patient with probable slowly progressive type 1 diabetes mellitus and endometrial cancer.

Iwaho Hazekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.